By HealthDay Staff HealthDay ReporterTHURSDAY, April 2, 2026 (HealthDay News) — A new daily pill to help with weight loss has ...

Foundayo is the first oral GLP-1 weight loss pill that doesn't require fasting.

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

FDA approved the Eli Lilly’s daily weight‑loss pill, a fast‑tracked GLP‑1 drug offering a new option for obesity treatment.

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

A new program helps patients safely transition off GLP-1 medications while maintaining results through nutrition, ...

AM Rx combines licensed provider care, expert coaching, and a digital-first patient experience to help eligible individuals explore ...

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

In TODAY.com's Expert Tip of the Day, a dietitian shares the dieting red flag she looks for in a weight loss program.

Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll ...